![Marinus Pharmaceuticals Inc](/common/images/company/N_MRNS.png)
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychi... Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19 pediatric epilepsy. Show more
Marinus Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before August 5, 2024 to Discuss Your Rights - MRNS PR Newswire NEW YORK, June 28, 2024 NEW YORK...
RAISE trial met its first co-primary endpoint demonstrating rapid cessation of status epilepticus in a highly refractory patient population The trial failed to achieve statistical significance on...
Enrollment complete in Phase 3 TrustTSC trial with topline data anticipated in the first half of Q4 2024 USPTO grants additional method of use patent for ganaxolone in TSC Marinus...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.16 | -11.8518518519 | 1.35 | 1.36 | 1.15 | 1189840 | 1.24888619 | CS |
4 | -0.27 | -18.4931506849 | 1.46 | 1.635 | 1.15 | 950095 | 1.38515102 | CS |
12 | -6.97 | -85.4166666667 | 8.16 | 8.28 | 1.11 | 2444057 | 1.43046329 | CS |
26 | -9.26 | -88.6124401914 | 10.45 | 11.26 | 1.11 | 1368010 | 2.86994154 | CS |
52 | -9.79 | -89.1621129326 | 10.98 | 11.26 | 1.11 | 958915 | 4.34503323 | CS |
156 | -17.49 | -93.6295503212 | 18.68 | 19.38 | 1.11 | 580517 | 5.98267387 | CS |
260 | -3.12 | -72.3897911833 | 4.31 | 20.04 | 0.77 | 1050225 | 4.39528958 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.